For the first time, a team of experts from the Technical University of Munich (TUM), RWTH Aachen University, and the German ...

For years, researchers have noted an alarming rise in colorectal cancer in younger people that’s not fully explained away by ...

Ozempic and Wegovy might help people avoid colon cancer as well as promote weight loss or control diabetes, a new study says.

A mere 10 minutes of daily physical activity could potentially safeguard the body from cancer. Recent research has revealed ...

Chronic inflammatory bowel disease is challenging to treat and carries a risk of complications, including the development of bowel cancer. Young people are particularly affected: when genetic ...

The study included 30 participants between the ages 50-78, all overweight or obese (a cancer risk) yet healthy otherwise.

GLP-1 receptor agonists like Ozempic and Wegovy may increase survival among patients with colon cancer, reported a new study published in Cancer Investigation. GLP-1 receptor agonists were originally ...

A research team at Queen’s University is seeking to understand how bowel cancer develops resistance to treatments including ...

The incidence of early-onset colorectal cancer has been increasing worldwide, a trend that has coincided with growing intake ...

Doctors are seeing colon cancer in people in their 20s and 30s. New research suggests it starts in infancy.